Literature DB >> 21458584

Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis.

Samuel M Behar1, Constance J Martin, Cláudio Nunes-Alves, Maziar Divangahi, Heinz G Remold.   

Abstract

Eicosanoids regulate whether human and murine macrophages infected with Mycobacterium tuberculosis die by apoptosis or necrosis. The death modality is important since apoptosis is associated with diminished pathogen viability and should be viewed as a form of innate immunity. Apoptotic vesicles derived from infected macrophages are also an important source of bacterial antigens that can be acquired by dendritic cells to prime antigen-specific T cells. This review integrates in vitro and in vivo data on how apoptosis of infected macrophages is linked to development of T cell immunity against M. tuberculosis.
Copyright © 2011 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458584      PMCID: PMC3130819          DOI: 10.1016/j.micinf.2011.03.002

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  52 in total

Review 1.  Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria.

Authors:  Florian Winau; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Cell Microbiol       Date:  2004-07       Impact factor: 3.715

2.  In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection.

Authors:  Tian Tian; Joshua Woodworth; Markus Sköld; Samuel M Behar
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

Review 3.  Mechanisms of MHC class I-restricted antigen processing and cross-presentation.

Authors:  Peter Cresswell; Anne L Ackerman; Alessandra Giodini; David R Peaper; Pamela A Wearsch
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

4.  Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells.

Authors:  Lu-Ann M Pozzi; Joseph W Maciaszek; Kenneth L Rock
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

5.  Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.

Authors:  Florian Winau; Stephan Weber; Subash Sad; Juana de Diego; Silvia Locatelli Hoops; Bernadette Breiden; Konrad Sandhoff; Volker Brinkmann; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Immunity       Date:  2006-01       Impact factor: 31.745

6.  Activation of human dendritic cells following infection with Mycobacterium tuberculosis.

Authors:  R A Henderson; S C Watkins; J L Flynn
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

7.  Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells.

Authors:  C Demangel; A G Bean; E Martin; C G Feng; A T Kamath; W J Britton
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

8.  Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production.

Authors:  Andre Bafica; Charles A Scanga; Charles Serhan; Fabiana Machado; Sandy White; Alan Sher; Julio Aliberti
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

9.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.

Authors:  M L Albert; B Sauter; N Bhardwaj
Journal:  Nature       Date:  1998-03-05       Impact factor: 49.962

10.  Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo.

Authors:  K Inaba; M Inaba; M Naito; R M Steinman
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Exosomes and other extracellular vesicles in host-pathogen interactions.

Authors:  Jeffrey S Schorey; Yong Cheng; Prachi P Singh; Victoria L Smith
Journal:  EMBO Rep       Date:  2014-12-08       Impact factor: 8.807

2.  Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.

Authors:  Fanny Tzelepis; Mark Verway; Jamal Daoud; Joshua Gillard; Kimya Hassani-Ardakani; Jonathan Dunn; Jeffrey Downey; Marilena Elena Gentile; Joanna Jaworska; Anthony Michel Jean Sanchez; Yohann Nédélec; Hojatollah Vali; Maryam Tabrizian; Arnold Scott Kristof; Irah Luther King; Luis Bruno Barreiro; Maziar Divangahi
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

Review 3.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

4.  Murine Flt3 ligand-generated plasmacytoid and conventional dendritic cells display functional differentiation in activation, inflammation, and antigen presentation during BCG infection in vitro.

Authors:  Chuang Meng; Xiaoyan Wang; Zhengzhong Xu; Maozhi Hu; Jiaying Liu; Zhiming Pan; Xiang Chen; Xinan Jiao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-05       Impact factor: 2.416

5.  TLR-4/microRNA-125a/NF-κB signaling modulates the immune response to Mycobacterium tuberculosis infection.

Authors:  Wenyi Niu; Bing Sun; Mingying Li; Junwei Cui; Jian Huang; Ligong Zhang
Journal:  Cell Cycle       Date:  2018-09-06       Impact factor: 4.534

Review 6.  Antigen-specific CD8(+) T cells and protective immunity to tuberculosis.

Authors:  Samuel M Behar
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 7.  Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis.

Authors:  Maziar Divangahi; Samuel M Behar; Heinz Remold
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Ingenol mebutate: potential for further development of cancer immunotherapy.

Authors:  Hung Q Doan; Nicholas Gulati; William R Levis
Journal:  J Drugs Dermatol       Date:  2012-10       Impact factor: 2.114

9.  Attenuated Mycobacterium tuberculosis SO2 vaccine candidate is unable to induce cell death.

Authors:  Adriana Aporta; Ainhoa Arbues; Juan I Aguilo; Marta Monzon; Juan J Badiola; Alba de Martino; Nadia Ferrer; Dessislava Marinova; Alberto Anel; Carlos Martin; Julian Pardo
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 10.  Current and novel approaches to vaccine development against tuberculosis.

Authors:  Mark J Cayabyab; Lilia Macovei; Antonio Campos-Neto
Journal:  Front Cell Infect Microbiol       Date:  2012-12-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.